Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Energy Vault
NRGV
$517M
| $7.15M | ﹤0.01% |
722,187
+247,874
| +52% | +$2.41M |
|
|
CBAY
2427
DELISTED
Cymabay Therapeutics
CBAY
| $7.15M | ﹤0.01% |
1,958,653
-144,159
| -7% | -$568K |
|
2428
BioLife Solutions
BLFS
$1.53B
| $7.15M | ﹤0.01% |
168,881
-491,755
| -74% | -$23.7M |
|
2429
CALL
Airbnb
ABNB
$89.9B
| $7.15M | ﹤0.01% |
42,600
+40,200
| +1,675% | +$6.14M |
|
2430
CALL
Chegg
CHGG
$110M
| $7.14M | ﹤0.01% |
105,000
-11,300
| -10% | -$920K |
|
2431
PUT
Monster Beverage
MNST
$94.3B
| $7.14M | ﹤0.01% |
160,800
-18,800
| -10% | -$889K |
|
2432
Primoris Services
PRIM
$4.58B
| $7.14M | ﹤0.01% |
291,534
-29,349
| -9% | -$789K |
|
2433
Rogers Corp
ROG
$2.21B
| $7.14M | ﹤0.01% |
38,278
+10,150
| +36% | +$2M |
|
2434
Vaxcyte
PCVX
$7.81B
| $7.14M | ﹤0.01% |
281,284
-34,329
| -11% | -$832K |
|
|
FVT
2435
DELISTED
Fortress Value Acquisition Corp. III
FVT
| $7.13M | ﹤0.01% |
731,381
-287,726
| -28% | -$2.81M |
|
2436
Golar LNG
GLNG
$5B
| $7.12M | ﹤0.01% |
548,846
-1,911,603
| -78% | -$22.1M |
|
2437
Q2 Holdings
QTWO
$3.8B
| $7.12M | ﹤0.01% |
88,802
+66,995
| +307% | +$6.14M |
|
|
PDCE
2438
DELISTED
PDC Energy, Inc.
PDCE
| $7.11M | ﹤0.01% |
150,003
-417,714
| -74% | -$17.4M |
|
|
FLYA.U
2439
DELISTED
SOAR Technology Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
FLYA.U
| $7.11M | ﹤0.01% |
+700,000
| New | +$7.12M |
|
2440
CALL
Healthcare Realty
HR
$7.28B
| $7.1M | ﹤0.01% |
+239,400
| New | +$6.98M |
|
2441
Better Home & Finance Holding
BETR
$443M
| $7.1M | ﹤0.01% |
14,299
-5,235
| -27% | -$2.6M |
|
2442
Nurix Therapeutics
NRIX
$2.41B
| $7.1M | ﹤0.01% |
236,883
-189,103
| -44% | -$5.84M |
|
2443
Organogenesis Holdings
ORGO
$305M
| $7.06M | ﹤0.01% |
495,863
-494,584
| -50% | -$7.68M |
|
2444
ZTO Express
ZTO
$18.3B
| $7.06M | ﹤0.01% |
230,229
-1,402,630
| -86% | -$40.2M |
|
|
SIVB
2445
DELISTED
SVB Financial Group
SIVB
| $7.05M | ﹤0.01% |
10,904
-43,106
| -80% | -$25M |
|
2446
A.O. Smith
AOS
$8.17B
| $7.05M | ﹤0.01% |
115,483
+103,611
| +873% | +$7.24M |
|
|
CERN
2447
CALL
DELISTED
Cerner Corp
CERN
| $7.05M | ﹤0.01% |
100,000
-120,000
| -55% | -$9.27M |
|
2448
Hope Bancorp
HOPE
$1.79B
| $7.05M | ﹤0.01% |
488,221
+17,685
| +4% | +$241K |
|
|
2449
Chegg
CHGG
$110M
| $7.04M | ﹤0.01% |
103,534
+78,991
| +322% | +$6.43M |
|
2450
Beyond Meat
BYND
$292M
| $7.03M | ﹤0.01% |
66,789
+38,963
| +140% | +$4.77M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.